Trial of Romidepsin and Bortezomib for Multiple Myeloma
Clinical trial NCT00765102 · TERMINATED
Trial details
- NCT number
- NCT00765102
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.